Featured
A Theory on the DEA's Cannabis Rescheduling Hearing
As the DEA rescheduling hearing enters its final stretch, one emerging theory is that opponents may have expected to fight one debate and found themselves in another.
2026-07-13T17:45:13.077Z
135 views
Last edited 2026-07-13T17:45:13.077Z
The hearing runs through July 15, with daily proceedings beginning at 9:00 a.m. ET and transcripts expected to be released as testimony unfolds.
DEA hearings on proposed federal marijuana rescheduling are now underway, opening a closely watched evidentiary phase in one of the most consequential cannabis policy proceedings in decades.
2026-06-29T17:33:50.181Z
691 views
Last edited 2026-07-06T14:57:19.614Z
Trulieve's restructuring was tied to a company-specific uplisting objective after Schedule III changes; most operators have not signaled comparable reorganizations.
2026-06-23T00:40:03.433Z
59 views
Last edited 2026-06-24T15:05:56.619Z
Governor Spanberger vetoes HB 642 and SB 542 amid dispute over retail launch timeline
Governor Spanberger vetoed cannabis retail legislation in May 2026, but reached a June 16 budget compromise with lawmakers for July 1, 2027 retail market launch with 6-8% state tax.
2026-05-29T02:25:53.904Z
10 views
Last edited 2026-06-22T23:34:43.675Z
Before the DEA hearing begins, the agency has already recognized accepted medical use for cannabis in a framework that overlaps heavily with modern state market products.
2026-06-20T01:14:29.522Z
107 views
Last edited 2026-06-20T01:15:09.622Z
Investors are revisiting familiar debates as policy uncertainty, liquidity shifts, and institutional positioning create a new narrative cycle.
Cannabis market participants are once again debating whether recent activity reflects structural change or another temporary sentiment swing.
2026-06-19T16:25:00.000Z
250 views
Last edited 2026-06-19T16:22:13.706Z
Federal lawmakers move to study real-time cannabis impairment technologies and driving standards
Congressional transportation legislation advances new research initiatives focused on cannabis impairment detection, real-time cognitive testing, and standardized roadway safety frameworks.
2026-05-28T18:09:59.077Z
13 views
Last edited 2026-06-19T16:09:49.585Z
Cannabis policy treats industry revenue as legitimate for taxation while still limiting full financial participation for businesses and workers.
2026-06-18T02:53:56.315Z
146 views
Last edited 2026-06-18T02:53:56.315Z
Recovery time can behave like an economic bottleneck, and cannabinoids are being studied for whether they marginally shift that constraint.
Evidence around cannabinoids and recovery remains early, but even small improvements in downtime could have cumulative labor and household effects across physically demanding sectors.
2026-06-06T17:46:02.820Z
43 views
Last edited 2026-06-06T17:54:49.277Z
Trulieve says it will begin trading on the NYSE as TRLV on June 10, a potential bellwether moment for U.S. cannabis operators seeking broader institutional access.
2026-06-05T22:00:53.002Z
14 views
Last edited 2026-06-06T04:18:40.026Z
Scientific interest in cannabinoids and Long COVID originates from identifiable biological and clinical observations — but evidence for treatment remains limited
Millions of people continue to experience symptoms months or years after recovering from COVID-19. Researchers studying Long COVID continue to investigate inflammation, neuroinflammation, and immune dysfunction — the same systems examined in cannabinoid research. Here is what the science currently supports.
2026-06-05T20:37:29.035Z
40 views
Last edited 2026-06-05T20:37:29.035Z
As cannabis laws evolve, some Tribal Nations are examining whether regulated cannabis can become another pathway for economic self-determination and diversified sovereignty-driven growth.
Tribal cannabis policy is not just a legal curiosity. It is a question of sovereignty, jurisdiction, and whether cannabis can become another tool of economic development in Native communities.
2026-06-02T23:58:02.2180226Z
5 views